A learned society dedicated to the vitreous as a structure in its own right: its biology, its interface with the retina, and its surgical management.
The Society advances scientific understanding, clinical management, and awareness of the vitreous as a structure in its own right: its composition, biomechanics and ageing; its role in vitreoretinal disease; and its replacement.
Ultrastructure, composition and rheology of the vitreous
Hyalocytes and the cell biology of the vitreous
Vitreoschisis and vitreous cortex remnants (VCR)
The vitreoretinal interface in health, ageing and disease
The vitreous contribution to macular pathology, rhegmatogenous retinal detachment (RRD), and proliferative vitreoretinopathy (PVR)
Vitreous opacities and their consequences and management
Inflammatory and infectious disease of the vitreous
Imaging and intraoperative visualisation of the vitreous
Vitreous proteomics and biomarkers for retinal disease
Surgical and enzymatic manipulation of the vitreous
Intravitreal drug delivery and pharmacokinetics
Vitreous substitutes, tamponades and replacement
Terminology, classification and reporting standards
Ultrastructure, hyalocyte biology, ageing and the molecular composition of the vitreous body.
Vitreoschisis, cortex remnants, PVR, retinal detachment and the surgical management of the interface.
Substitutes, tamponade agents and the physical and biological demands of vitreous replacement.
Public communication and outreach, including social media, to raise awareness of the field.
Education and training, including courses held at meetings of other societies.
Multicentre research, registries and shared protocols, promoted across member institutions.
Publication of scientific information, independently or in partnership with an existing journal.
A recurring scientific meeting, held at least once every two years.
First scientific meeting: to be scheduled once the founding board and the first membership circle are confirmed.
Any physician, scientist or other professional with demonstrable involvement in the field of work, admitted on the recommendation of an existing member.
Residents, fellows and doctoral candidates. Reduced dues.
Members who no longer practise or research full time and request this status.
Appointed by the general assembly for exceptional contribution to the field. Dues exempt.
Professionals employed by commercial organisations active in the field of work. Admitted by two-thirds vote of the board.
Nominated by a recognised patient organisation. Take part in consensus panels and in setting research priorities. Dues exempt.
Members, members in training and emeritus members hold voting rights and are eligible for office. Honorary members, company affiliates and patient representatives do not. The board may in addition confer the honorary designation Fellow of the International Vitreous Society for a substantial contribution to the Society.
To be constituted as a vereniging (a non-profit association) with full legal capacity under the law of the Netherlands, seat in Rotterdam. Statutes are in preparation and will be published here once adopted.
Statutes are in preparation and the founding board is being formed. If your work touches the vitreous, its interface with the retina, or its surgical replacement, we would like to hear from you, whether as a founding member, a member in training, or in an honorary capacity, before the first general meeting.